The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation
Open accessAbstract
The central role of T cell activation in hepatocellular injury has been well documented. In this article, we provide evidence suggesting that T cells may also play a protective role in liver disease by releasing interleukin-22 (IL-22), a recently identified T cell-derived cytokine whose biological significance is unclear. IL-22 messenger RNA and protein expression are significantly elevated in T cell-mediated hepatitis induced by concanavalin A (ConA) but are less extensively elevated in the carbon tetrachloride-induced liver injury model. Activated CD3+ T cells are likely responsible for the production of IL-22 in the liver after injection of ConA. The IL-22 receptor is normally expressed at high levels by hepatocytes and further induced after ConA injection. IL-22 blockade with a neutralizing antibody reduces signal transducer and activator of transcription factor 3 (STAT3) activation and worsens liver injury in T cell-mediated hepatitis, whereas injection of recombinant IL-22 attenuates such injury. In vitro treatment with recombinant IL-22 or overexpression of IL-22 promotes cell growth and survival in human hepatocellular carcinoma HepG2 cells. Stable overexpression of IL-22 in HepG2 cells constitutively activates STAT3 and induces expression of a variety of antiapoptotic (e.g., Bcl-2, Bcl-xL, Mcl-1) and mitogenic (e.g., c-myc, cyclin D1, Rb2, CDK4) proteins. Blocking STAT3 activation abolishes the antiapoptotic and mitogenic actions of IL-22 in hepatic cells. In conclusion, the T cell-derived cytokine IL-22 is a survival factor for hepatocytes; this suggests that T cell activation may also prevent and repair liver injury by releasing hepatoprotective cytokine IL-22 in addition to its previously documented central role in hepatocellular injury. (Hepatology 2004;39:1332-1342.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A T cell-dependent experimental liver injury in mice inducible by concanavalin A.
Tiegs, G., Hentschel, J., & Wendel, A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115836 · Cited by 1,074
Bromberg, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15617 · Cited by 770
Xie, M.-H., Aggarwal, S., Ho, W.-H., Foster, J., Zhang, Z., Stinson, J., Wood, W. I., Goddard, A. D., & Gurney, A. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005304200 · Cited by 540
Bharti, A. C., Donato, N., & Aggarwal, B. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3863 · Cited by 508
Dumoutier, L., Louahed, J., & Renauld, J.-C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1814 · Cited by 500
Lejeune, D., Dumoutier, L., Constantinescu, S., Kruijer, W., Schuringa, J. J., & Renauld, J.-C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204204200 · Cited by 477
Turkson, J., Ryan, D., Kim, J. S., Zhang, Y., Chen, Z., Haura, E., Laudano, A., Sebti, S., Hamilton, A. D., & Jove, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107527200 · Cited by 448
Camargo, C. A., Madden, J. F., Gao, W., Selvan, R. S., & Clavien, P. (1997) · Hepatology · doi:10.1002/hep.510260619 · Cited by 421
Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence
Cerny, A., & Chisari, F. V. (1999) · Hepatology · doi:10.1002/hep.510300312 · Cited by 410
Identification of the Functional Interleukin-22 (IL-22) Receptor Complex
Kotenko, S. V., Izotova, L. S., Mirochnitchenko, O. V., Esterova, E., Dickensheets, H., Donnelly, R. P., & Pestka, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007837200 · Cited by 400
Dumoutier, L., Van Roost, E., Colau, D., & Renauld, J.-C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170291697 · Cited by 365
Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth
Leong, P. L., Andrews, G. A., Johnson, D. E., Dyer, K. F., Xi, S., Mai, J. C., Robbins, P. D., Gadiparthi, S., Burke, N. A., Watkins, S. F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0534764100 · Cited by 340
Differential Cd4+ and Cd8+ T–Cell Responsiveness in Hepatitis C Virus Infection
Chang, K.-M., Thimme, R., Melpolder, J. J., Oldach, D., Pemberton, J., Moorhead-Loudis, J., McHutchison, J. G., Alter, H. J., & Chisari, F. V. (2001) · Hepatology · doi:10.1053/jhep.2001.21162 · Cited by 336
Minami, M., Inoue, M., Wei, S., Takeda, K., Matsumoto, M., Kishimoto, T., & Akira, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3963 · Cited by 335
The interleukin-10 family of cytokines
Fickenscher, H., Hör, S., Küpers, H., Knappe, A., Wittmann, S., & Sticht, H. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02149-4 · Cited by 331
Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice
Kovalovich, K., DeAngelis, R. A., Li, W., Furth, E. E., Ciliberto, G., & Taub, R. (2000) · Hepatology · doi:10.1002/hep.510310123 · Cited by 298
Kovalovich, K., Li, W., DeAngelis, R., Greenbaum, L. E., Ciliberto, G., & Taub, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100740200 · Cited by 280
Opposing roles of STAT1 and STAT3 in T cell–mediated hepatitis: regulation by SOCS
Hong, F., Jaruga, B., Kim, W. H., Radaeva, S., El-Assal, O. N., Tian, Z., Nguyen, V.-A., & Gao, B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15841 · Cited by 270
Self-citationStat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms
Haga, S., Terui, K., Zhang, H. Q., Enosawa, S., Ogawa, W., Inoue, H., Okuyama, T., Takeda, K., Akira, S., Ogino, T., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17970 · Cited by 237
Hepatoprotection via the IL-6/Stat3 pathway
Taub, R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19974 · Cited by 217
Current and novel immunosuppressive therapy for autoimmune hepatitis
Heneghan, M. A., & McFarlane, I. G. (2002) · Hepatology · doi:10.1053/jhep.2002.30991 · Cited by 210
Pan, H., Hong, F., Radaeva, S., & Gao, B. (2004) · PubMed · Cited by 186
Self-citationHong, F., Kim, W.-H., Tian, Z., Jaruga, B., Ishac, E., Shen, X., & Gao, B. (2002) · Oncogene · doi:10.1038/sj.onc.1205016 · Cited by 179
Self-citationInterleukin-6/Glycoprotein 130-dependent Pathways Are Protective during Liver Regeneration
Wuestefeld, T., Klein, C., Streetz, K. L., Betz, U., Lauber, J., Buer, J., Manns, M. P., Müller, W., & Trautwein, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208470200 · Cited by 176
Mediators of inflammation and acute phase response in the liver.
Streetz, K. L., Wüstefeld, T., Klein, C., Manns, M. P., & Trautwein, C. (2001) · PubMed · Cited by 175
Acinar Cells of the Pancreas Are a Target of Interleukin-22
Aggarwal, S., Xie, M.-H., Maruoka, M., Foster, J., & Gurney, A. L. (2001) · Journal of Interferon & Cytokine Research · doi:10.1089/107999001317205178 · Cited by 172
(1999) · PubMed · Cited by 171
Rosen, H. R., Miner, C., Sasaki, A. W., Lewinsohn, D. M., Conrad, A. J., Bakke, A., Bouwer, A. H. G., & Hinrichs, D. J. (2002) · Hepatology · doi:10.1053/jhep.2002.30293 · Cited by 168
Interleukin 6/Gp130–Dependent Pathways Are Protective During Chronic Liver Diseases
Streetz, K. L., Tacke, F., Leifeld, L., Wüstefeld, T., Graw, A., Klein, C., Kamino, K., Spengler, U., Kreipe, H., Kubicka, S., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50268 · Cited by 167
The lymphoid liver: Considerations on pathways to autoimmune injury
Kita, H., Van De Water, J., Gershwin, M. E., & Mackay, I. R. (2001) · Gastroenterology · doi:10.1053/gast.2001.22441 · Cited by 158
Evidence That Cyclin D1 Mediates Both Growth and Proliferation Downstream of TOR in Hepatocytes
Nelsen, C. J., Rickheim, D. G., Tucker, M. M., Hansen, L. K., & Albrecht, J. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209374200 · Cited by 142
(2001) · PubMed · Cited by 136
STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP
Spiotto, M. T., & Chung, T. D. (2000) · The Prostate · doi:10.1002/(sici)1097-0045(20000201)42:2<88::aid-pros2>3.0.co;2-p · Cited by 134
Interferon-α activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes
Radaeva, S., Jaruga, B., Hong, F., Kim, W., Fan, S., Cai, H., Strom, S. C., Liu, Y., El-Assal, O. N., & Gao, B. (2002) · Gastroenterology · doi:10.1053/gast.2002.32388 · Cited by 128
Self-citationSun, Z., Klein, A. S., Radaeva, S., Hong, F., El-Assal, O. N., Pan, H.-N., Jaruga, B., Bátkai, S., Hoshino, S., Tian, Z., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00696-6 · Cited by 127
Self-citationSantoni‐Rugiu, E., Preisegger, K., Kiss, A., Audolfsson, T., Shiota, G., Schmidt, E. V., & Thorgeirsson, S. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9577 · Cited by 121
Santoni‐Rugiu, E., Nagy, P., Jensen, M. R., Factor, V. M., & Thorgeirsson, S. S. (1996) · Europe PMC (PubMed Central) · Cited by 120
Cell-mediated hepatic injury in alcoholic liver disease
Chedid, A., Mendenhall, C. L., Moritz, T. E., French, S. W., Chen, T., Morgan, T. R. M., Roselle, G. A., Nemchausky, B. A., Tamburro, C. H., Schiff, E. R., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90034-a · Cited by 117
Intrahepatic T Cells in Hepatitis B
Rehermann, B. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1263 · Cited by 107
StreetZ, K. L., Wüstefeld, T., Klein, C., Kallen, K.-J., Tronche, F., Betz, U. A. K., Schütz, G., Manns, M. P., Müller, W., & Trautwein, C. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00901-6 · Cited by 94
Tsukada, Y.-I., Miyazawa, K., & Kitamura, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010890200 · Cited by 89
Phenotypic and Functional Characterization of Intrahepatic T Lymphocytes During Chronic Hepatitis C
Leroy, V., Vigan-Womas, I., Mosnier, J., Dufeu‐Duchesne, T., Pernollet, M., Zarski, J., Marche, P. N., & Jouvin‐Marche, E. (2003) · Hepatology · doi:10.1002/hep.1840380409 · Cited by 80
Modulation of liver injury by interleukin-10.
Louis, H., Moine, O. L., Goldman, M., & Deviere, J. M. (2003) · PubMed · Cited by 72
Amino Acids Regulate Hepatocyte Proliferation through Modulation of Cyclin D1 Expression
Nelsen, C. J., Rickheim, D. G., Tucker, M. M., McKenzie, T. J., Hansen, L. K., Pestell, R. G., & Albrecht, J. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302360200 · Cited by 59
Shima, N., Stolz, D. B., Miyazaki, M., Gohda, E., Higashio, K., & Michalopoulos, G. K. (1998) · Journal of Cellular Physiology · Cited by 26
Animal Models of Autoimmune Hepatitis
Jaeckel, E. (2002) · Seminars in liver disease (Print) · doi:10.1055/s-2002-35703 · Cited by 10
Cited by
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A., & Hymowitz, S. G. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101312 · Cited by 1,925
The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
Ouyang, W., Kolls, J. K., & Zheng, Y. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.004 · Cited by 1,700
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J.-C., & Stockinger, B. (2008) · Nature · doi:10.1038/nature06881 · Cited by 1,634
IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation
Ouyang, W., & O’Garra, A. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.020 · Cited by 1,072
Metadata
- Authors
- Radaeva, S., Sun, R., Pan, H.-N., Hong, F., & Gao, B.
- Venue
- Hepatology
- Published
- 2004-05
- Volume
- 39
- Issue
- 5
- Pages
- 1332-1342
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2091845172
- Cited by
- 597
- References
- 46
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.